Roche Cervical Cancer Portfolio

Roche’s response to the COVID-19 pandemic

Roche is deeply committed to supporting the global response to put an end to the COVID-19 pandemic

SARS-CoV-2 Antigen Self Test Nasal

cobas h 232 – POC System

On-the-spot care: Immediate diagnosis and management of patients with signs and symptoms of cardiovascular disease

 

SARS-CoV-2 Antigen Self Test Nasal

SARS-CoV-2 Antigen Self Test Nasal

新冠病毒抗原自行檢測套裝 (鼻腔)

有關更多訊息,請按此處

 

Our business

Roche Diagnostics serves customers spanning the entire healthcare spectrum - from commercial laboratories, research institutions and hospitals to physicians and patients.

See more